Literature DB >> 23549967

Thyroid eye disease.

Michel J Belliveau1, David R Jordan.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23549967      PMCID： PMC3680560          DOI： 10.1503/cmaj.121815

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

Review 1.  Graves' ophthalmopathy.

Authors:  Rebecca S Bahn
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

Review 2.  Cigarette smoking and thyroid eye disease: a systematic review.

Authors:  J Thornton; S P Kelly; R A Harrison; R Edwards
Journal:  Eye (Lond)       Date:  2006-09-15       Impact factor: 3.775

Review 3.  Treating the thyroid in the presence of Graves' ophthalmopathy.

Authors:  Laszlo Hegedüs; Steen J Bonnema; Terry J Smith; Thomas H Brix
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-06       Impact factor: 4.690

4.  Clinical features of Graves' ophthalmopathy in an incidence cohort.

Authors:  G B Bartley; V Fatourechi; E F Kadrmas; S J Jacobsen; D M Ilstrup; J A Garrity; C A Gorman
Journal:  Am J Ophthalmol       Date:  1996-03       Impact factor: 5.258
  4 in total
  3 in total

Review 1.  Ophthalmic clues to the endocrine disorders.

Authors:  Z Liu; Y Chen; Z Lin; X Shi
Journal:  J Endocrinol Invest       Date:  2016-08-27       Impact factor: 4.256

2.  The Therapeutic Effect of Combination of Orbital Decompression Surgery and Methylprednisolone Pulse Therapy on Patients with Bilateral Dysthyroid Optic Neuropathy.

Authors:  Jianan Xu; Huijing Ye; Guo Chen; Jingqiao Chen; Rongxin Chen; Huasheng Yang
Journal:  J Ophthalmol       Date:  2020-02-19       Impact factor: 1.909

Review 3.  Illicit drugs: Effects on eye.

Authors:  Deepika Dhingra; Savleen Kaur; Jagat Ram
Journal:  Indian J Med Res       Date:  2019-09       Impact factor: 2.375
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.